Research Analysts Set Expectations for PTCT FY2026 Earnings
PTC Therapeutics, Inc. (NASDAQ:PTCT – Free Report) – Analysts at Cantor Fitzgerald issued their FY2026 EPS estimates for PTC Therapeutics in a research report issued to clients and investors on Monday, June 9th. Cantor Fitzgerald analyst K. Kluska forecasts that the biopharmaceutical company will post earnings per share of ($2.69) for the year. Cantor Fitzgerald […]
PTC Therapeutics, Inc. (NASDAQ:PTCT – Free Report) – Analysts at Cantor Fitzgerald issued their FY2026 EPS estimates for PTC Therapeutics in a research report issued to clients and investors on Monday, June 9th. Cantor Fitzgerald analyst K. Kluska forecasts that the biopharmaceutical company will post earnings per share of ($2.69) for the year. Cantor Fitzgerald […]
